The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells

Diabetes

Volumn 46, Issue 3, 1997, Pages 463-472

  Higashi, Takayuki ^a   Sano, Hiroyuki ^a   Saishoji, Tetsushi ^a   Ikeda, Kazuyoshi ^a   Jinnouchi, Yoshiiteru ^a   Kanzaki, Tetsuto ^b   Morisaki, Nobuhiro ^b   Rauvala, Heikki ^c   Shichiri, Motoaki ^a   Horiuchi, Seikoh ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; BOVINE SERUM ALBUMIN; OXIDIZED LOW DENSITY LIPOPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL MIGRATION; CHEMOTAXIS; CULTURE MEDIUM; ENDOCYTOSIS; FOAM CELL; GLYCATION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; RABBIT; SMOOTH MUSCLE FIBER;

EID: 14444283590     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.3.463     Document Type: Article

References (62)

1. Maillard LC: Action des acides amines sur les sucres; formation des melanoidines par voie methodique. CR Acad Sci Paris 154:66-68, 1912
2. Finot PA: Modification of proteins. Am Chem Soc 198:91-124, 1982
3. Araki N, Ueno N, Chacrabarti B, Morino Y, Horiuchi S: Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem 267:10211-10214, 1992
4. 2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 92:1243-1252, 1993
5. Yamada K, Nakano H, Nakayama M, Nozaki O, Miura Y, Suzuki S, Tsuchida H, Mimura N, Araki N, Horiuchi S: Immunohistochemical study of human advanced glycosylation end products (AGE) in chronic renal failure. Clin Nephrol 42:354-361, 1994
6. Nakayama H, Mitsuhashi T, Kuwajima S, Aoki S, Kuroda Y, Itoh T, Koike T: Immunochemical detection of advanced glycation end products in lens crystallins from streptozotocin-induced diabetic rat. Diabetes 42:345-350, 1993
7. Mitsuhashi T, Nakayama H, Itoh T, Kuwajima S, Aoki S, Asumi T, Koike T: Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rat. Diabetes 42:826-832, 1993
8. Makita Z, Vlassara H, Cerami A, Bucala R: Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 267:5133-5138, 1992
9. Vlassara H, Bucala R, Striker L: Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70:138-151, 1994
10. Nakamura Y, Horii Y, Nishino T, Shiiki H, Sakaguchi Y, Kagoshima T, Dohi K, Makita Z, Vlassara H, Bucala R: Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Pathol 143:1649-1656, 1994
11. Kume S, Takeya M, Mori T, Araki N, Suzuki H, Horiuchi S, Kodama T, Miyauchi Y, Takahashi K: Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta using a novel specific monoclonal antibody. Am J Pathol 147:654-667, 1995
12. Yui S, Sasaki T, Araki N, Horiuchi S, Yamazaki M: Induction of macrophage growth by advanced glycation end products of the Maillard reaction. J Immunol 152:1943-1949, 1994
13. 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. J Clin Invest 93:521-528, 1994
14. Kirstein M, Aston C, Hintz R, Vlassara H: Receptor-specific induction of insulin-like growth factor I (IGF-I) in human monocytes by advanced glycosylation endproduct-modified proteins. J Clin Invest 90:439-446, 1992
15. Vlassara H, Brownlee M, Manogue KR, Dinarello C, Pasagian A: Cachectin/TNF and IL-1 induced by glucose modified proteins: role in normal tissue remodeling. Science 240:1546-1548, 1988
16. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H: Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of PDGF: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 87:9010-9014, 1990
17. Schmidt AM, Yan SD, Brett J, Mora R, Nowygrod R, Stem D: Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest 91:2155-2168, 1993
18. Tezuka M, Koyama N, Morisaki N, Saito Y, Yoshida S, Araki N, Horiuchi S: Angiogenic effects of advanced glycation end products of the Maillard reaction on cultured human umbilical cord vein endothelial cells. Biochem Biophys Res Commun 193:674-680, 1993
19. Esposito C, Gerlach H, Brett J, Stern D, Vlassara H: Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties J Exp Med 170:1387-1407, 1989
20. Skolnik EY, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H: Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodeling and diabetic nephropathy. J Exp Med 174:931-939, 1991
21. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ: Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci USA 89:2873-2877, 1992
22. Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, Esposito C, Hegarty H, Hurley W, Clauss M, Wang F, Pan YE, Tsang TC, Stern D: Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267:14987-14997, 1992
23. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YE, Elliston K, Stern D, Shaw A: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:14998-15004, 1992
24. Brett J, Schmidt AM, Yan SD, Zou YS, Weidman E, Pinsky D, Nowygrod R, Neeper M, Przysiecki C, Shaw A, Migheli A, Stern D: Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 143:1699-1712, 1993
25. Yang BZ, Makita Z, Horii Y, Brunelle S, Cerami A, Sehajpal P, Suthanthiran M, Vlassara H: Two novel rat liver membrane proteins that bind advanced glycosylation endproducte: relationship to macrophage receptor for glucose-modified proteins. J Exp Med 174:515-524, 1991
26. Vlassara H, Li YM, Imani F, Wojciechowicz D, Yang Z, Liu FT, Cerami A; Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Mol Med 1:634-646, 1995
27. Araki N, Higashi T, Mori T, Shibayama R, Kawabe Y, Kodama T, Takahashi K, Shichiri M, Horiuchi S: Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end-products of the Maillard reaction. Eur J Biochem 230:408-415, 1995
28. Naito M, Suzuki H, Mon T, Matsumoto A, Kodama T, Takahashi K: Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. Am J Pathol 141:591-599, 1992
29. Yla-Herttuala S, Rosenfeld ME, Parthasarathy E, Sigal E, Sarkioja T, Witztum JL, Steinberg D: Gene expression in macrophage-rich human atherosclerotic lesions: 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-proteins adducts. J Clin Invest 87:1146-1152, 1991
30. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809, 1993
31. Horiuchi S, Araki N, Morino Y: Immunochemical approach to characterize advanced glycation end products of Maillard reaction: evidence for the presence of a common structure. J Biol Chem 266:7329-7332, 1991
32. Koyama N, Koshikawa T, Morisaki N, Saito Y, Yoshida S: Bifunctional effects of transforming growth factor-β on migration of cultured rat smooth muscle cells. Biochem Biophys Res Commun 169:725-729, 1990
33. Sakai M, Miyazaki A, Hakamata H, Sasaki T, Yui T, Yamazaki M, Shichiri M, Horiuchi S: Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophage. J Biol Chem 269:31430-31435, 1994
34. Takata K, Horiuchi S, Araki N, Shiga M, Saitoh M, Morino Y: Endocytic uptake of nonenzymatically glycosylated proteins is mediated by a scavenger receptor for aldehyde-modified proteins. J Biol Chem 263:14819-14825, 1988
35. Pongor S, Ulrich PC, Bencsath FA, Cerami A: Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose. Proc Natl Acad Sci USA 81:2684-2688, 1984
36. Steinbrecher UP, Witzum JL, Parathasarathy S, Steinberg D: Copper-catalyzed oxidation of low density lipoproteins in the absence of cells mimics the modification produced by incubation with endothelial cells. Arteriosclerosis 7:135-142, 1987
37. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH: Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85, 1985
38. Parkkinen J, Raulo E, Merenmies J, Nolo R, Kajander EO, Baumann M, Rauvala H: Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. J Biol Chem 268:19726-19738, 1993
39. Fischer-Dzoga K, Jones RM, Vesselinovitch D, Wissler RW: Ultrastructural and immunohistochemical studies of primary cultures of aortic medial cells. Exp Mol Pathol 18:162-176, 1976
40. Ikeda T, Lioubin MN, Marquardt H: Human transforming growth factor type β2: production by a prostatic adenocarcinoma cell line, purification, and initial characterization. Biochemistry 26:2406-2410, 1987
41. Ishiyama M, Shiga M, Sasamoto K, Mizoguchi M, He P: A new sulfonated tetrazolium salt that produces a highly water-soluble formazan dye. Chem Pharm Bull 41:1118-1122, 1993
42. Tamaki K, Okuda S, Ando T, Iwamoto T, Nakayama M, Fujishima M: TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 45:525-536, 1994
43. 2 affinity purification. J Immunol 142:1536-1541, 1989
44. Morisaki N, Kawano M, Koyama N, Koshikawa T, Umemiya K, Saito Y, Yoshida S: Effect of transforming growth factor-β1 on growth of aortic smooth muscle cells. Atherosclerosis 88:227-234, 1991
45. Takata K, Horiuchi S, Araki N, Shiga M, Saitoh M, Morino Y: Scavenger receptor of human monocytic leukemia cell line (THP-1) and murine macrophages for nonenzymatically glycosylated proteins. Biochem Biophys Acta 986:18-26, 1989
46. Vlassara H, Brownlee M, Cerami A: Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors. J Exp Med 164:1301-1309, 1986
47. 2 in expression of the scavenger pathway in cultured aortic smooth muscle cells stimulated with phorbol 12-myristate 13-acetate. Biochem J 303:247-253, 1994
48. Inaba T, Gotoda T, Shimano H, Shimada M, Harada K, Kozaki K, Watanabe Y, Hoh E, Motoyoshi K, Yazaki Y, Yamada N: Platelet-derived growth factor induces c-fms and scavenger receptor genes in vascular smooth muscle cells. J Biol Chem 267:13107-13112, 1992
49. Pitas RE: Expression of the acetyl low density lipoprotein receptor by rabbit fibroblast and smooth muscle cells: up-regulation by phorbol esters. J Biol Chem 265:12722-12727, 1990
50. Bickel PE, Freeman MW: Rabbit aortic smooth muscle cells express inducible macrophage scavenger receptor messenger RNA that is absent from endothelial cells. J Clin Invest 90:1450-1457, 1992
51. Ritthaler U, Deng Y, Zhang Y, Greten J, Abel M, Sido B, Allenberg J, Otto G, Roth H, Bierhaus A, Ziegler R, Schmidt AM, Waldherr R, Wahl P, Stern DM, Nawroth PP: Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am J Pathol 146:688-693, 1995
52. Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, Nagashima M, Lundh ER, Vijay S, Nitecki D, Morser J, Stern D, Schmidt AM: The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. J Biol Chem 270:25752-15761, 1995
53. Fredman J, Pauly RR, Stern D, Schmidt AM, Yan SD, Brett J, Monticone R, Crow MT: Advanced glycation endproducts interacting with their receptors activate vascular smooth muscle cells: induction of chemoattractants for smooth muscle cells and monocytes. Circulation 90 (Suppl.):I-291, 1994
54. Schmidt AM, Hasu M, Popov D, Zhang JH, Chen J, Yan SD, Brett J, Cao R, Kuwabara K, Costache G, Simionescu N, Simionescu M, Stern D: Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc Natl Acad Sci USA 91:8807-8811, 1994
55. Vlassara H, Brownlee M, Cerami A: High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Proc Natl Acad Sci USA 82:5588-5592, 1985
56. Saito Y, Bujo H, Morisaki N, Shirai K, Yoshida S: Proliferation and LDL binding of cultured intimai smooth muscle cells from rabbits. Atherosclerosis 69:161-164, 1988
57. Inaba T, Yamada N, Gotoda T, Shimano H, Shimada M, Momomura K, Kadowaki T, Motoyoshi K, Tsukada T, Morisaki N, Saito Y, Yoshida S, Takaku F, Yazaki Y: Expression of M-CSF receptor encoded by c-fms on smooth muscle cells derived from arteriosclerotic lesion. J Biol Chem 267:5693-5699, 1992
58. Li H, Freeman MW, Libby P: Regulation of smooth muscle cell scavenger receptor expression by atherogenic diets and in vitro by cytokines. J Clin Invest 95:122-133, 1994
59. 1 in rabbit arteries injured with a balloon catheter. Arterioscler Thromb Vasc Biol 15:1951-1957, 1995
60. Koyama N, Koshikawa T, Morisaki N, Saito Y, Yoshida S: Secretion of a potent new migration factor for smooth muscle cells (SMC) by cultured SMC. Atherosclerosis 86:219-226, 1991
61. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R: TGF-β induces bimodal proliferation of connective tissue cells via complex controls of an autocrine PDGF loop. Cell 63:515-524, 1990
62. Goodman LV, Majack RA: Vascular smooth muscle cells express distinct transforming growth factor-β receptor phenotypes as a function of cell density in culture. J Biol Chem 264:5241-5244, 1989